{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T15:24:12Z","timestamp":1787412252937,"version":"build-2736575974"},"reference-count":148,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"DOI":"10.1007\/s00702-026-03204-1","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T14:49:16Z","timestamp":1787410156000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Frailty in Parkinson\u2019s disease: time to integrate it into treatment decision-making?"],"prefix":"10.1007","author":[{"given":"Manon","family":"Auffret","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Fazio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Pisani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Odin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Santens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Lorenzl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,22]]},"reference":[{"issue":"3","key":"3204_CR1","doi-asserted-by":"publisher","first-page":"414","DOI":"10.18502\/jimc.v7i3.15719","volume":"7","author":"A Aghaz","year":"2024","unstructured":"Aghaz A, Ghelichi L, Shahriyari A, Noori S, Banari A (2024) The prevalence of dysphagia in Parkinson\u2019s disease: a systematic review and meta-analysis. Journal of Iranian Medical Council 7(3):414\u2013429. https:\/\/doi.org\/10.18502\/jimc.v7i3.15719","journal-title":"Journal of Iranian Medical Council"},{"key":"3204_CR2","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.parkreldis.2007.10.004","volume":"14","author":"NN Ahmed","year":"2008","unstructured":"Ahmed NN, Sherman SJ, Vanwyck D (2008) Frailty in Parkinson\u2019s disease and its clinical implications. Parkinsonism Relat Disord 14:334\u2013337. https:\/\/doi.org\/10.1016\/j.parkreldis.2007.10.004","journal-title":"Parkinsonism Relat Disord"},{"key":"3204_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.70558","author":"P Antenucci","year":"2026","unstructured":"Antenucci P, Gozzi A, Colucci F et al (2026) Risk-benefit considerations in deep brain stimulation discontinuation for late-stage Parkinson\u2019s disease. Movement Disorders Clinical Practice. https:\/\/doi.org\/10.1002\/mdc3.70558","journal-title":"Movement Disorders Clinical Practice"},{"key":"3204_CR4","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1007\/s00415-012-6557-8","volume":"259","author":"A Antonini","year":"2012","unstructured":"Antonini A, Barone P, Marconi R et al (2012) The progression of non-motor symptoms in Parkinson\u2019s disease and their contribution to motor disability and quality of life. J Neurol 259:2621\u20132631. https:\/\/doi.org\/10.1007\/s00415-012-6557-8","journal-title":"J Neurol"},{"key":"3204_CR5","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s40120-025-00856-1","volume":"15","author":"A Antonini","year":"2026","unstructured":"Antonini A, Bergmans B, Kern DS et al (2026) Foslevodopa\/Foscarbidopa in younger patients earlier within advanced Parkinson\u2019s disease: post hoc analysis of a randomized trial. Neurol Ther 15:309\u2013324. https:\/\/doi.org\/10.1007\/s40120-025-00856-1","journal-title":"Neurol Ther"},{"issue":"1","key":"3204_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2025.107872","volume":"139","author":"M Auffret","year":"2025","unstructured":"Auffret M (2025) Apomorphine: past, present and future in Parkinson\u2019s disease and beyond. Parkinsonism Relat Disord 139(1):107872. https:\/\/doi.org\/10.1016\/j.parkreldis.2025.107872","journal-title":"Parkinsonism Relat Disord"},{"key":"3204_CR7","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/s00702-023-02668-9","volume":"130","author":"M Auffret","year":"2023","unstructured":"Auffret M, Weiss D, Stocchi F et al (2023) Access to device-aided therapies in advanced Parkinson\u2019s disease: navigating clinician biases, patient preference, and prognostic uncertainty. Journal of Neural Transmission 130:1411\u20131432. https:\/\/doi.org\/10.1007\/s00702-023-02668-9","journal-title":"Journal of Neural Transmission"},{"key":"3204_CR8","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s00702-025-02989-x","volume":"132","author":"M Auffret","year":"2025","unstructured":"Auffret M, Borovecki F, Heim B et al (2025) Far from being the end of the road: taking a closer look at neuropalliative care in Parkinson\u2019s disease. Journal of Neural Transmission 132:1727\u20131750. https:\/\/doi.org\/10.1007\/s00702-025-02989-x","journal-title":"Journal of Neural Transmission"},{"key":"3204_CR9","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/mdc3.13161","volume":"8","author":"P Azevedo","year":"2021","unstructured":"Azevedo P, Aquino CC, Fasano A (2021) Surgical management of Parkinson\u2019s disease in the elderly. Movement Disorders Clinical Practice 8:500\u2013509. https:\/\/doi.org\/10.1002\/mdc3.13161","journal-title":"Movement Disorders Clinical Practice"},{"key":"3204_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2020.554307","volume":"11","author":"M Bartoli","year":"2020","unstructured":"Bartoli M, Palermo S, Cipriani GE, Amanzio M (2020) A possible association between executive dysfunction and frailty in patients with neurocognitive disorders. Front Psychol 11:554307. https:\/\/doi.org\/10.3389\/fpsyg.2020.554307","journal-title":"Front Psychol"},{"key":"3204_CR11","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1007\/s00415-021-10873-3","volume":"269","author":"D Belvisi","year":"2022","unstructured":"Belvisi D, Canevelli M, Costanzo M et al (2022) The role of frailty in Parkinson\u2019s disease: a cross-sectional study. Journal of Neurology 269:3006\u20133014. https:\/\/doi.org\/10.1007\/s00415-021-10873-3","journal-title":"Journal of Neurology"},{"key":"3204_CR12","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jdcr.2025.10.076","volume":"69","author":"M Blaise","year":"2025","unstructured":"Blaise M, Puppo A, Cosmin A et al (2025) Multiple aseptic cellulitis following continuous subcutaneous injection of foslevodopa-foscarbidopa: two case reports. JAAD Case Reports 69:78\u201380. https:\/\/doi.org\/10.1016\/j.jdcr.2025.10.076","journal-title":"JAAD Case Reports"},{"key":"3204_CR13","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1002\/mdc3.70060","volume":"12","author":"S Broh\u00e9e","year":"2025","unstructured":"Broh\u00e9e S, Roze E, Grabli D et al (2025) Cognitive and psychiatric adverse effects of foslevodopa\/foscarbidopa in patients with Parkinson\u2019s disease. Movement Disorders Clinical Practice 12:1028\u20131030. https:\/\/doi.org\/10.1002\/mdc3.70060","journal-title":"Movement Disorders Clinical Practice"},{"key":"3204_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.598035","volume":"12","author":"Y Cai","year":"2021","unstructured":"Cai Y, Feng F, Wei Q, Jiang Z, Ou R, Shang H (2021) Sarcopenia in patients with Parkinson\u2019s disease: a systematic review and meta-analysis. Front Neurol 12:598035. https:\/\/doi.org\/10.3389\/fneur.2021.598035","journal-title":"Front Neurol"},{"key":"3204_CR15","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1159\/000381229","volume":"41","author":"ID Cameron","year":"2015","unstructured":"Cameron ID, Kurrle SE (2015) Frailty and rehabilitation. Interdiscip Top Gerontol Geriatr 41:137\u2013150. https:\/\/doi.org\/10.1159\/000381229","journal-title":"Interdiscip Top Gerontol Geriatr"},{"key":"3204_CR16","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S1474-4422(24)00291-6","volume":"23","author":"M Canevelli","year":"2024","unstructured":"Canevelli M, Jackson-Tarlton C, Rockwood K (2024) Frailty for neurologists: perspectives on how frailty influences care planning. Lancet Neurol 23:1147\u20131157. https:\/\/doi.org\/10.1016\/S1474-4422(24)00291-6","journal-title":"Lancet Neurol"},{"key":"3204_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.70489","author":"KR Chaudhuri","year":"2026","unstructured":"Chaudhuri KR, Bergmans B, Freire-Alvarez E et al (2026) Considerations for Initiation and Maintenance of Foslevodopa\/Foscarbidopa for Advanced Parkinson\u2019s Disease. Mov Disord Clin Pract. https:\/\/doi.org\/10.1002\/mdc3.70489","journal-title":"Mov Disord Clin Pract"},{"key":"3204_CR18","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41531-024-00664-8","volume":"10","author":"N Che","year":"2024","unstructured":"Che N, Ou R, Li C et al (2024) Plasma GFAP as a prognostic biomarker of motor subtype in early Parkinson\u2019s disease. NPJ Parkinsons Dis 10:48. https:\/\/doi.org\/10.1038\/s41531-024-00664-8","journal-title":"NPJ Parkinsons Dis"},{"key":"3204_CR19","doi-asserted-by":"publisher","first-page":"104700","DOI":"10.1016\/j.nbd.2019.104700","volume":"134","author":"Z Chen","year":"2020","unstructured":"Chen Z, Li G, Liu J (2020) Autonomic dysfunction in Parkinson\u2019s disease: Implications for pathophysiology, diagnosis, and treatment. Neurobiol Dis 134:104700. https:\/\/doi.org\/10.1016\/j.nbd.2019.104700","journal-title":"Neurobiol Dis"},{"key":"3204_CR20","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s12603-022-1766-z","volume":"26","author":"S Chen","year":"2022","unstructured":"Chen S, Wang Y, Wang Z et al (2022) Sleep Duration and Frailty Risk among Older Adults: Evidence from a Retrospective, Population-Based Cohort Study. J Nutr health aging 26:383\u2013390. https:\/\/doi.org\/10.1007\/s12603-022-1766-z","journal-title":"J Nutr health aging"},{"key":"3204_CR21","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1016\/j.clinph.2020.06.018","volume":"131","author":"G Cosentino","year":"2020","unstructured":"Cosentino G, Tassorelli C, Prunetti P et al (2020) Reproducibility and reaction time of swallowing as markers of dysphagia in parkinsonian syndromes. Clin Neurophysiol 131:2200\u20132208. https:\/\/doi.org\/10.1016\/j.clinph.2020.06.018","journal-title":"Clin Neurophysiol"},{"key":"3204_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-026-02148-4","author":"M Costanzo","year":"2026","unstructured":"Costanzo M, Canevelli M, De Bartolo MI et al (2026) Relationship between frailty and disease progression in Parkinson\u2019s disease: a 3-year longitudinal study. GeroScience. https:\/\/doi.org\/10.1007\/s11357-026-02148-4","journal-title":"GeroScience"},{"key":"3204_CR23","doi-asserted-by":"publisher","first-page":"112360","DOI":"10.1016\/j.exger.2024.112360","volume":"186","author":"M Dallaire","year":"2024","unstructured":"Dallaire M, Houde-Thibeault A, Bouchard-Tremblay J et al (2024) Impact of frailty and sex-related differences on postural control and gait in older adults with Parkinson\u2019s Disease. Exp Gerontol 186:112360. https:\/\/doi.org\/10.1016\/j.exger.2024.112360","journal-title":"Exp Gerontol"},{"key":"3204_CR24","doi-asserted-by":"publisher","first-page":"101925","DOI":"10.1016\/j.arr.2023.101925","volume":"87","author":"A Debain","year":"2023","unstructured":"Debain A, Loosveldt FA, Knoop V et al (2023) Frail older adults are more likely to have autonomic dysfunction: A systematic review and meta-analysis. Ageing Res Rev 87:101925. https:\/\/doi.org\/10.1016\/j.arr.2023.101925","journal-title":"Ageing Res Rev"},{"key":"3204_CR25","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1001\/jamaneurol.2014.1272","volume":"71","author":"MR DeLong","year":"2014","unstructured":"DeLong MR, Huang KT, Gallis J et al (2014) Effect of advancing age on outcomes of deep brain stimulation for Parkinson disease. JAMA Neurol 71:1290\u20131295. https:\/\/doi.org\/10.1001\/jamaneurol.2014.1272","journal-title":"JAMA Neurol"},{"key":"3204_CR26","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1001\/jamaneurol.2017.1125","volume":"74","author":"E De Pablo-Fernandez","year":"2017","unstructured":"De Pablo-Fernandez E, Tur C, Revesz T et al (2017) Association of Autonomic Dysfunction With Disease Progression and Survival in Parkinson Disease. JAMA Neurol 74:970\u2013976. https:\/\/doi.org\/10.1001\/jamaneurol.2017.1125","journal-title":"JAMA Neurol"},{"key":"3204_CR27","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41531-024-00642-0","volume":"10","author":"P Dodet","year":"2024","unstructured":"Dodet P, Houot M, Leu-Semenescu S et al (2024) Sleep disorders in Parkinson\u2019s disease, an early and multiple problem. npj Parkinsons Dis 10:46. https:\/\/doi.org\/10.1038\/s41531-024-00642-0","journal-title":"npj Parkinsons Dis"},{"issue":"4","key":"3204_CR28","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/ggi.14362","volume":"22","author":"J Ebina","year":"2022","unstructured":"Ebina J, Ebihara S, Kano O (2022) Similarities, differences and overlaps between frailty and Parkinson\u2019s disease. Geriatr Gerontol Int 22(4):259\u2013270. https:\/\/doi.org\/10.1111\/ggi.14362","journal-title":"Geriatr Gerontol Int"},{"key":"3204_CR29","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/ene.13844","volume":"26","author":"M Fabbri","year":"2019","unstructured":"Fabbri M, Zibetti M, Beccaria L et al (2019) Levodopa\/carbidopa intestinal gel infusion and weight loss in Parkinson\u2019s disease. Eur J Neurol 26:490\u2013496. https:\/\/doi.org\/10.1111\/ene.13844","journal-title":"Eur J Neurol"},{"key":"3204_CR30","doi-asserted-by":"publisher","first-page":"e13707","DOI":"10.1002\/jcsm.13707","volume":"16","author":"R Fatima","year":"2025","unstructured":"Fatima R, Kim Y, Baek S et al (2025) C-Terminal Agrin Fragment as a Biomarker for Sarcopenia: A Systematic Review and Meta-Analysis. J Cachexia Sarcopenia Muscle 16:e13707. https:\/\/doi.org\/10.1002\/jcsm.13707","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"3204_CR31","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41574-018-0059-4","volume":"14","author":"C Franceschi","year":"2018","unstructured":"Franceschi C, Garagnani P, Parini P et al (2018) Inflammaging: a new immune\u2013metabolic viewpoint for age-related diseases. Nat Rev Endocrinol 14:576\u2013590. https:\/\/doi.org\/10.1038\/s41574-018-0059-4","journal-title":"Nat Rev Endocrinol"},{"key":"3204_CR32","doi-asserted-by":"publisher","first-page":"101665","DOI":"10.1016\/j.neuchi.2025.101665","volume":"71","author":"RM Franco","year":"2025","unstructured":"Franco RM, Soares C, Oliveira A et al (2025) Rethinking age barriers in Parkinson\u2019s disease for deep brain stimulation. Neurochirurgie 71:101665. https:\/\/doi.org\/10.1016\/j.neuchi.2025.101665","journal-title":"Neurochirurgie"},{"key":"3204_CR33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41531-023-00605-x","volume":"10","author":"A Frank","year":"2024","unstructured":"Frank A, Bendig J, Schnalke N et al (2024) Serum neurofilament indicates accelerated neurodegeneration and predicts mortality in late-stage Parkinson\u2019s disease. npj Parkinsons Dis 10:14. https:\/\/doi.org\/10.1038\/s41531-023-00605-x","journal-title":"npj Parkinsons Dis"},{"key":"3204_CR34","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s43587-020-00017-z","volume":"1","author":"LP Fried","year":"2021","unstructured":"Fried LP, Cohen AA, Xue Q-L et al (2021) The physical frailty syndrome as a transition from homeostatic symphony to cacophony. Nat Aging 1:36\u201346. https:\/\/doi.org\/10.1038\/s43587-020-00017-z","journal-title":"Nat Aging"},{"key":"3204_CR35","doi-asserted-by":"publisher","first-page":"1355627","DOI":"10.3389\/fneur.2024.1355627","volume":"15","author":"T Fukuoka","year":"2024","unstructured":"Fukuoka T, Hori K, Ono T (2024) Quantitative evaluation of swallowing function in Parkinson\u2019s disease using tongue pressure measurement: a mini-review. Front Neurol 15:1355627. https:\/\/doi.org\/10.3389\/fneur.2024.1355627","journal-title":"Front Neurol"},{"key":"3204_CR36","doi-asserted-by":"publisher","first-page":"e12671","DOI":"10.1016\/j.heliyon.2022.e12671","volume":"9","author":"M Gao","year":"2023","unstructured":"Gao M, Zhang C, Gao L et al (2023) Association between C-reactive protein-albumin ratio and overall survival in Parkinson\u2019s disease using publicly available data: A retrospective cohort study. Heliyon 9:e12671. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e12671","journal-title":"Heliyon"},{"key":"3204_CR37","doi-asserted-by":"publisher","first-page":"107215","DOI":"10.1016\/j.parkreldis.2024.107215","volume":"130","author":"\u00c1 Garc\u00eda-Bustillo","year":"2025","unstructured":"Garc\u00eda-Bustillo \u00c1, Ram\u00edrez-Sanz JM, Garrido-Labrador JL et al (2025) A multidisciplinary telemedicine approach for managing frailty in Parkinson\u2019s disease. A longitudinal, case-control study. Parkinsonism Relat Disord 130:107215. https:\/\/doi.org\/10.1016\/j.parkreldis.2024.107215","journal-title":"Parkinsonism Relat Disord"},{"key":"3204_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2025.107950","author":"M Garon","year":"2025","unstructured":"Garon M, Scharfenort M, Antonini A et al (2025) Cognitive outcomes of infusion therapies in Parkinson\u2019s disease: A comprehensive systematic review. Parkinsonism Relat Disord. https:\/\/doi.org\/10.1016\/j.parkreldis.2025.107950. 138:","journal-title":"Parkinsonism Relat Disord"},{"key":"3204_CR39","doi-asserted-by":"publisher","first-page":"e200534","DOI":"10.1212\/CPJ.0000000000200534","volume":"15","author":"L Ge","year":"2025","unstructured":"Ge L, Kimura Y, Kakuda K et al (2025) Atypical Psychosis in Parkinson Disease. Neurol Clin Pract 15:e200534. https:\/\/doi.org\/10.1212\/CPJ.0000000000200534","journal-title":"Neurol Clin Pract"},{"key":"3204_CR40","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41531-025-01126-5","volume":"11","author":"J Gervasoni","year":"2025","unstructured":"Gervasoni J, Marino C, Imarisio A et al (2025) Independent serum metabolomics approaches identify disrupted glutamic acid and serine metabolism in Parkinson\u2019s disease patients. npj Parkinsons Dis 11:274. https:\/\/doi.org\/10.1038\/s41531-025-01126-5","journal-title":"npj Parkinsons Dis"},{"key":"3204_CR41","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3233\/JPD-230117","volume":"14","author":"JG Goldman","year":"2024","unstructured":"Goldman JG, Volpe D, Ellis TD et al (2024) Delivering Multidisciplinary Rehabilitation Care in Parkinson\u2019s Disease: An International Consensus Statement. J Parkinsons Dis 14:135\u2013166. https:\/\/doi.org\/10.3233\/JPD-230117","journal-title":"J Parkinsons Dis"},{"key":"3204_CR42","doi-asserted-by":"publisher","first-page":"1000527","DOI":"10.3389\/fneur.2022.1000527","volume":"13","author":"S Gong","year":"2022","unstructured":"Gong S, Gao Y, Liu J et al (2022) The prevalence and associated factors of dysphagia in Parkinson\u2019s disease: A systematic review and meta-analysis. Front Neurol 13:1000527. https:\/\/doi.org\/10.3389\/fneur.2022.1000527","journal-title":"Front Neurol"},{"key":"3204_CR43","doi-asserted-by":"publisher","first-page":"107065","DOI":"10.1016\/j.nbd.2025.107065","volume":"215","author":"P Grillo","year":"2025","unstructured":"Grillo P, Di Martino D, Calculli A et al (2025) Physical exercise modulates plasma irisin levels in endurance athletes: Implications for Parkinson\u2019s disease. Neurobiol Dis 215:107065. https:\/\/doi.org\/10.1016\/j.nbd.2025.107065","journal-title":"Neurobiol Dis"},{"key":"3204_CR44","doi-asserted-by":"publisher","first-page":"156272","DOI":"10.1016\/j.metabol.2025.156272","volume":"169","author":"M Gui","year":"2025","unstructured":"Gui M, Lv L, Hu S et al (2025) Sarcopenia in Parkinson\u2019s disease: from pathogenesis to interventions. Metabolism 169:156272. https:\/\/doi.org\/10.1016\/j.metabol.2025.156272","journal-title":"Metabolism"},{"key":"3204_CR45","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1093\/ajhp\/zxz217","volume":"76","author":"M Guti\u00e9rrez-Valencia","year":"2019","unstructured":"Guti\u00e9rrez-Valencia M, Mart\u00ednez-Velilla N (2019) Frailty in the older person: Implications for pharmacists. Am J Health Syst Pharm 76:1980\u20131987. https:\/\/doi.org\/10.1093\/ajhp\/zxz217","journal-title":"Am J Health Syst Pharm"},{"key":"3204_CR46","doi-asserted-by":"publisher","first-page":"e47547","DOI":"10.7759\/cureus.47547","volume":"15","author":"JU Hancock","year":"2023","unstructured":"Hancock JU, Price AL, Zaki PG et al (2023) The Five-Factor Modified Frailty Index as a Predictor of Outcomes in Deep Brain Stimulation Surgery for Parkinson\u2019s Disease. Cureus 15:e47547. https:\/\/doi.org\/10.7759\/cureus.47547","journal-title":"Cureus"},{"key":"3204_CR47","doi-asserted-by":"publisher","DOI":"10.14802\/jmd.26058","author":"L Hartmann","year":"2026","unstructured":"Hartmann L, Seppi K, Gattermeyer-Kell L et al (2026) Psychosis after weight loss during continuous subcutaneous foslevodopa\/foscarbidopa therapy - a case series. J Mov Disord. https:\/\/doi.org\/10.14802\/jmd.26058","journal-title":"J Mov Disord"},{"key":"3204_CR48","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s41531-021-00247-x","volume":"7","author":"JM Hatcher-Martin","year":"2021","unstructured":"Hatcher-Martin JM, McKay JL, Pybus AF et al (2021) Cerebrospinal fluid biomarkers in Parkinson\u2019s disease with freezing of gait: an exploratory analysis. npj Parkinsons Dis 7:105. https:\/\/doi.org\/10.1038\/s41531-021-00247-x","journal-title":"npj Parkinsons Dis"},{"key":"3204_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/jcm15010063","author":"D Hern\u00e1ndez-Triana","year":"2025","unstructured":"Hern\u00e1ndez-Triana D, P\u00e1ez-Garc\u00eda S, Mena A et al (2025) Parkinson\u2019s Disease and Frailty: A Two-Way Link Across Aging. J Clin Med. https:\/\/doi.org\/10.3390\/jcm15010063","journal-title":"J Clin Med"},{"key":"3204_CR50","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3390\/jcm15010063","volume":"15","author":"D Hern\u00e1ndez-Triana","year":"2026","unstructured":"Hern\u00e1ndez-Triana D, P\u00e1ez-Garc\u00eda S, Mena A et al (2026) Parkinson\u2019s Disease and Frailty: A Two-Way Link Across Aging. J Clin Med 15:63. https:\/\/doi.org\/10.3390\/jcm15010063","journal-title":"J Clin Med"},{"key":"3204_CR51","doi-asserted-by":"publisher","first-page":"118","DOI":"10.18773\/austprescr.2022.031","volume":"45","author":"SN Hilmer","year":"2022","unstructured":"Hilmer SN, Gnjidic D (2022) The anticholinergic burden: from research to practice. Aust Prescr 45:118\u2013120. https:\/\/doi.org\/10.18773\/austprescr.2022.031","journal-title":"Aust Prescr"},{"key":"3204_CR52","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1093\/ageing\/afab003","volume":"50","author":"SN Hilmer","year":"2021","unstructured":"Hilmer SN, Kirkpatrick CMJ (2021) New Horizons in the impact of frailty on pharmacokinetics: latest developments. Age Ageing 50:1054\u20131063. https:\/\/doi.org\/10.1093\/ageing\/afab003","journal-title":"Age Ageing"},{"key":"3204_CR53","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1093\/geroni\/igx004.4751","volume":"1","author":"SN Hilmer","year":"2017","unstructured":"Hilmer SN, PHARMACOKINETICS AND PHARMACODYNAMICS OF FRAILTY AND POLYPHARMACY: PRECLINICAL INSIGHTS (2017) Innov Aging 1:1299. https:\/\/doi.org\/10.1093\/geroni\/igx004.4751","journal-title":"Innov Aging"},{"key":"3204_CR54","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.mad.2019.111119","volume":"181","author":"SN Hilmer","year":"2019","unstructured":"Hilmer SN, Wu H, Zhang M (2019) Biology of frailty: Implications for clinical pharmacology and drug therapy in frail older people. Mech Ageing Dev 181:22\u201328. https:\/\/doi.org\/10.1016\/j.mad.2019.111119","journal-title":"Mech Ageing Dev"},{"key":"3204_CR55","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s43587-021-00099-3","volume":"1","author":"SE Howlett","year":"2021","unstructured":"Howlett SE, Rutenberg AD, Rockwood K (2021) The degree of frailty as a translational measure of health in aging. Nat Aging 1:651\u2013665. https:\/\/doi.org\/10.1038\/s43587-021-00099-3","journal-title":"Nat Aging"},{"key":"3204_CR56","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.radcr.2025.11.073","volume":"21","author":"C Hughes","year":"2026","unstructured":"Hughes C, Fazio T, Umstad C (2026) Iatrogenic hemoperitoneum and sigmoid colon injury from malpositioned apomorphine infusion device in advanced Parkinson\u2019s disease. Radiol Case Rep 21:1324\u20131329. https:\/\/doi.org\/10.1016\/j.radcr.2025.11.073","journal-title":"Radiol Case Rep"},{"key":"3204_CR57","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41398-024-02991-z","volume":"14","author":"A Imarisio","year":"2024","unstructured":"Imarisio A, Yahyavi I, Gasparri C et al (2024) Serum dysregulation of serine and glycine metabolism as predictive biomarker for cognitive decline in frail elderly subjects. Transl Psychiatry 14:281. https:\/\/doi.org\/10.1038\/s41398-024-02991-z","journal-title":"Transl Psychiatry"},{"key":"3204_CR58","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S1474-4422(24)00170-4","volume":"23","author":"A Iranzo","year":"2024","unstructured":"Iranzo A, Cochen De Cock V, Fantini ML et al (2024) Sleep and sleep disorders in people with Parkinson\u2019s disease. Lancet Neurol 23:925\u2013937. https:\/\/doi.org\/10.1016\/S1474-4422(24)00170-4","journal-title":"Lancet Neurol"},{"key":"3204_CR59","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s00702-025-03006-x","volume":"133","author":"P Jenner","year":"2026","unstructured":"Jenner P, Nyholm D (2026) COMT inhibition with entacapone for patients with Parkinson\u2019s disease and motor complications: the novelty of continuous infusion. J Neural Transm (Vienna) 133:361\u2013375. https:\/\/doi.org\/10.1007\/s00702-025-03006-x","journal-title":"J Neural Transm (Vienna)"},{"key":"3204_CR60","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejim.2018.04.023","volume":"56","author":"U Junius-Walker","year":"2018","unstructured":"Junius-Walker U, Onder G, Soleymani D et al (2018) The essence of frailty: A systematic review and qualitative synthesis on frailty concepts and definitions. Eur J Intern Med 56:3\u201310. https:\/\/doi.org\/10.1016\/j.ejim.2018.04.023","journal-title":"Eur J Intern Med"},{"key":"3204_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/nu14235194","author":"KW Kacprzyk","year":"2022","unstructured":"Kacprzyk KW, Milewska M, Zarnowska A, Panczyk M, Rokicka G, Szostak-Wegierek D (2022) Prevalence of Malnutrition in Patients with Parkinson\u2019s Disease: A Systematic Review. Nutrients. https:\/\/doi.org\/10.3390\/nu14235194","journal-title":"Nutrients"},{"key":"3204_CR62","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1007\/s12031-022-01970-7","volume":"72","author":"A Karim","year":"2022","unstructured":"Karim A, Iqbal MS, Muhammad T, Qaisar R (2022) Evaluation of Sarcopenia Using Biomarkers of the Neuromuscular Junction in Parkinson\u2019s Disease. J Mol Neurosci 72:820\u2013829. https:\/\/doi.org\/10.1007\/s12031-022-01970-7","journal-title":"J Mol Neurosci"},{"key":"3204_CR63","doi-asserted-by":"publisher","first-page":"111386","DOI":"10.1016\/j.jocn.2025.111386","volume":"138","author":"AH Khan","year":"2025","unstructured":"Khan AH, Heintzelman KE, Fletcher DM et al (2025) Modified frailty index-11 (mFI-11) measured frailty as a predictor of postoperative outcomes in Parkinson\u2019s disease patients undergoing deep brain stimulation: A national inpatient sample analysis. J Clin Neurosci 138:111386. https:\/\/doi.org\/10.1016\/j.jocn.2025.111386","journal-title":"J Clin Neurosci"},{"key":"3204_CR64","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1056\/NEJMra2301292","volume":"391","author":"DH Kim","year":"2024","unstructured":"Kim DH, Rockwood K (2024a) Frailty in Older Adults. N Engl J Med 391:538\u2013548. https:\/\/doi.org\/10.1056\/NEJMra2301292","journal-title":"N Engl J Med"},{"key":"3204_CR65","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.parkreldis.2019.07.025","volume":"66","author":"R Kim","year":"2019","unstructured":"Kim R, Yoo D, Im JH et al (2019) REM sleep behavior disorder predicts functional dependency in early Parkinson\u2019s disease. Parkinsonism Relat Disord 66:138\u2013142. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.07.025","journal-title":"Parkinsonism Relat Disord"},{"key":"3204_CR66","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s00702-025-02911-5","volume":"133","author":"T Koeglsperger","year":"2026","unstructured":"Koeglsperger T, Berberovic E, Dresel C et al (2026) Real-world experience with continuous subcutaneous foslevodopa\/foscarbidopa infusion: insights and recommendations. J Neural Transm 133:347\u2013359. https:\/\/doi.org\/10.1007\/s00702-025-02911-5","journal-title":"J Neural Transm"},{"key":"3204_CR67","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1002\/mdc3.13810","volume":"10","author":"PL Kukkle","year":"2023","unstructured":"Kukkle PL, Garg D, Merello M (2023) Continuous Subcutaneous Infusion Delivery of Apomorphine in Parkinson\u2019s Disease: A Systematic Review. Mov Disord Clin Pract 10:1253\u20131267. https:\/\/doi.org\/10.1002\/mdc3.13810","journal-title":"Mov Disord Clin Pract"},{"key":"3204_CR68","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41531-022-00421-9","volume":"8","author":"B Labeit","year":"2022","unstructured":"Labeit B, Berkovich E, Claus I et al (2022) Dysphagia for medication in Parkinson\u2019s disease. NPJ Parkinsons Dis 8:156. https:\/\/doi.org\/10.1038\/s41531-022-00421-9","journal-title":"NPJ Parkinsons Dis"},{"key":"3204_CR69","doi-asserted-by":"publisher","first-page":"100089","DOI":"10.1016\/j.prdoa.2021.100089","volume":"4","author":"MR Landers","year":"2021","unstructured":"Landers MR, Jacobson KM, Matsunami NE et al (2021) A vicious cycle of fear of falling avoidance behavior in Parkinson\u2019s disease: A path analysis. Clin Parkinsonism Relat Disorders 4:100089. https:\/\/doi.org\/10.1016\/j.prdoa.2021.100089","journal-title":"Clin Parkinsonism Relat Disorders"},{"key":"3204_CR70","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s40266-018-0629-0","volume":"36","author":"MD Latt","year":"2019","unstructured":"Latt MD, Lewis S, Zekry O, Fung VSC (2019) Factors to Consider in the Selection of Dopamine Agonists for Older Persons with Parkinson\u2019s Disease. Drugs Aging 36:189\u2013202. https:\/\/doi.org\/10.1007\/s40266-018-0629-0","journal-title":"Drugs Aging"},{"key":"3204_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2025.12.014","author":"T-L Lee","year":"2025","unstructured":"Lee T-L, Lu M-K (2025) Deep brain stimulation and magnetic resonance-guided focused ultrasound in Parkinsonism and related disorders: State-of-the-Art and future prospects. J Formos Med Assoc. https:\/\/doi.org\/10.1016\/j.jfma.2025.12.014","journal-title":"J Formos Med Assoc"},{"key":"3204_CR72","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1177\/01939459251365725","volume":"47","author":"J Lee","year":"2025","unstructured":"Lee J, Park J, Yoo S et al (2025) Frailty in Patients With Parkinson\u2019s Disease in Community and Clinical Settings: A Scoping Review. West J Nurs Res 47:1118\u20131129. https:\/\/doi.org\/10.1177\/01939459251365725","journal-title":"West J Nurs Res"},{"key":"3204_CR73","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2025.1723707","author":"G Li","year":"2025","unstructured":"Li G, Hong G, Huang J et al (2025) Modeling and validation in Parkinson\u2019s disease patients with frailty. Front Neurosci. https:\/\/doi.org\/10.3389\/fnins.2025.1723707","journal-title":"Front Neurosci"},{"key":"3204_CR74","doi-asserted-by":"publisher","first-page":"1449973","DOI":"10.3389\/fneur.2025.1449973","volume":"16","author":"M Liang","year":"2025","unstructured":"Liang M, Hou L, Liang J, Bao S (2025) Ameliorating motor performance and quality of life in Parkinson\u2019s disease: a comparison of deep brain stimulation and focused ultrasound surgery. Front Neurol 16:1449973. https:\/\/doi.org\/10.3389\/fneur.2025.1449973","journal-title":"Front Neurol"},{"issue":"3","key":"3204_CR75","doi-asserted-by":"publisher","first-page":"e0227238","DOI":"10.1371\/journal.pone.0227238","volume":"15","author":"DP Lima","year":"2020","unstructured":"Lima DP, de Almeida SB, Bonfadini JC, de Luna JRG, de Alencar MS, Pinheiro-Neto EB, Viana-J\u00fanior AB, Veras SRO, Sobreira-Neto MA, Roriz-Filho JS, Braga-Neto P (2020) Clinical correlates of sarcopenia and falls in Parkinson\u2019s disease. PLoS ONE 15(3):e0227238. https:\/\/doi.org\/10.1371\/journal.pone.0227238","journal-title":"PLoS ONE"},{"key":"3204_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinsp.2025.100776","volume":"80","author":"DP Lima","year":"2025","unstructured":"Lima DP, Gomes VC, Luna J et al (2025) Assessment of sarcopenia tools as predictors of falls in patients with mild to moderate Parkinson\u2019s Disease: A cohort study. Clinics 80:100776. https:\/\/doi.org\/10.1016\/j.clinsp.2025.100776","journal-title":"Clinics"},{"key":"3204_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2019.00283","volume":"11","author":"WC Lin","year":"2019","unstructured":"Lin WC, Huang YC, Leong CP, Chen MH, Chen HL, Tsai NW, Tso HH, Chen PC, Lu CH (2019) Associations Between Cognitive Functions and Physical Frailty in Patients With Parkinson\u2019s Disease. Front Aging Neurosci 11:283. https:\/\/doi.org\/10.3389\/fnagi.2019.00283","journal-title":"Front Aging Neurosci"},{"key":"3204_CR78","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/ana.78110","volume":"99","author":"L Lorefice","year":"2026","unstructured":"Lorefice L, Pellecchia MT (2026) Frailty across Neurological Diseases: Why Sex and Gender Matter. Ann Neurol 99:297\u2013311. https:\/\/doi.org\/10.1002\/ana.78110","journal-title":"Ann Neurol"},{"key":"3204_CR79","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000193","volume":"3","author":"L-F Lue","year":"2016","unstructured":"Lue L-F, Schmitz CT, Snyder NL et al (2016) Converging mediators from immune and trophic pathways to identify Parkinson disease dementia. Neurol Neuroimmunol Neuroinflamm 3:e193. https:\/\/doi.org\/10.1212\/NXI.0000000000000193","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"3204_CR80","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13092191","volume":"13","author":"M Lungu","year":"2025","unstructured":"Lungu M, Oprea VD, Apostol LL et al (2025) Levodopa-Carbidopa-Entacapone Intestinal Gel for Advanced Parkinson\u2019s Disease-Results from a Monocentric Study Evaluating Both Motor and Non-Motor Manifestations. Biomedicines 13:2191. https:\/\/doi.org\/10.3390\/biomedicines13092191","journal-title":"Biomedicines"},{"key":"3204_CR81","doi-asserted-by":"publisher","first-page":"1238588","DOI":"10.3389\/fnagi.2023.1238588","volume":"15","author":"Y Luo","year":"2023","unstructured":"Luo Y, Liu J, Chen D, Liu M, Yuan Y, Hu J, Wu J, Wang F, Liu C, Chen J, Mao C (2023) How sleep quality affects activities of daily living in Parkinson\u2019s disease: the mediating role of disease severity and the moderating role of cognition. Front Aging Neurosci 15:1238588. https:\/\/doi.org\/10.3389\/fnagi.2023.1238588","journal-title":"Front Aging Neurosci"},{"key":"3204_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/s40734-018-0074-6","author":"NS Luthra","year":"2018","unstructured":"Luthra NS, Kim S, Zhang Y, Investigators NINDSNET-PD et al (2018) Characterization of vitamin D supplementation and clinical outcomes in a large cohort of early Parkinson\u2019s disease. J Clin Mov Disord. https:\/\/doi.org\/10.1186\/s40734-018-0074-6","journal-title":"J Clin Mov Disord"},{"key":"3204_CR83","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2018.00001","volume":"10","author":"K Ma","year":"2018","unstructured":"Ma K, Xiong N, Shen Y, Han C, Liu L, Zhang G, Wang L, Guo S, Guo X, Xia Y, Wan F, Huang J, Lin Z, Wang T (2018) Weight Loss and Malnutrition in Patients with Parkinson\u2019s Disease: Current Knowledge and Future Prospects. Front Aging Neurosci 10:1. https:\/\/doi.org\/10.3389\/fnagi.2018.00001","journal-title":"Front Aging Neurosci"},{"issue":"6","key":"3204_CR84","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1002\/mds.27709","volume":"34","author":"M Mancini","year":"2019","unstructured":"Mancini M, Bloem BR, Horak FB, Lewis SJG, Nieuwboer A, Nonnekes J (2019) Clinical and methodological challenges for assessing freezing of gait: Future perspectives. Mov Disord 34(6):783\u2013790. https:\/\/doi.org\/10.1002\/mds.27709","journal-title":"Mov Disord"},{"key":"3204_CR85","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1001\/jamaneurol.2024.1220","volume":"81","author":"R Mart\u00ednez-Fern\u00e1ndez","year":"2024","unstructured":"Mart\u00ednez-Fern\u00e1ndez R, Natera-Villalba E, Rodr\u00edguez-Rojas R et al (2024) Staged Bilateral MRI-Guided Focused Ultrasound Subthalamotomy for Parkinson Disease. JAMA Neurol 81:638\u2013644. https:\/\/doi.org\/10.1001\/jamaneurol.2024.1220","journal-title":"JAMA Neurol"},{"key":"3204_CR86","doi-asserted-by":"publisher","first-page":"100095","DOI":"10.1016\/j.prdoa.2021.100095","volume":"4","author":"JM McMillan","year":"2021","unstructured":"McMillan JM, Michalchuk Q, Goodarzi Z (2021) Frailty in Parkinson\u2019s disease: A systematic review and meta-analysis. Clin Park Relat Disord 4:100095. https:\/\/doi.org\/10.1016\/j.prdoa.2021.100095","journal-title":"Clin Park Relat Disord"},{"key":"3204_CR87","doi-asserted-by":"publisher","first-page":"7341","DOI":"10.1038\/s41598-022-11358-7","volume":"12","author":"N Mielke","year":"2022","unstructured":"Mielke N, Schneider A, Huscher D et al (2022) Gender differences in frailty transition and its prediction in community-dwelling old adults. Sci Rep 12:7341. https:\/\/doi.org\/10.1038\/s41598-022-11358-7","journal-title":"Sci Rep"},{"issue":"2","key":"3204_CR88","first-page":"56","volume":"12","author":"M Moghaddasi","year":"2013","unstructured":"Moghaddasi M, Mamarabadi M, Aghaii M (2013) Serum 25-hydroxyvitamin D3 concentration in Iranian patients with Parkinson\u2019s disease. Iran J Neurol 12(2):56\u201359 PMID: 24250903; PMCID: PMC3829282","journal-title":"Iran J Neurol"},{"key":"3204_CR89","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3233\/JPD-212769","volume":"12","author":"H Nawaz","year":"2022","unstructured":"Nawaz H, Sargent L, Quilon H et al (2022) Anticholinergic Medication Burden in Parkinson\u2019s Disease Outpatients. J Parkinsons Dis 12:599\u2013606. https:\/\/doi.org\/10.3233\/JPD-212769","journal-title":"J Parkinsons Dis"},{"key":"3204_CR90","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s40262-024-01466-0","volume":"64","author":"NN Ngcobo","year":"2025","unstructured":"Ngcobo NN (2025) Influence of Ageing on the Pharmacodynamics and Pharmacokinetics of Chronically Administered Medicines in Geriatric Patients: A Review. Clin Pharmacokinet 64:335\u2013367. https:\/\/doi.org\/10.1007\/s40262-024-01466-0","journal-title":"Clin Pharmacokinet"},{"key":"3204_CR91","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1177\/08919887211060017","volume":"35","author":"D Nimmons","year":"2022","unstructured":"Nimmons D, Bhanu C, Orlu M et al (2022) Orthostatic Hypotension and Antiparkinsonian Drugs: A Systematic Review and Meta-analysis. J Geriatr Psychiatry Neurol 35:639\u2013654. https:\/\/doi.org\/10.1177\/08919887211060017","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"3204_CR92","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/ageing\/afaa219","volume":"50","author":"R O\u2019Caoimh","year":"2021","unstructured":"O\u2019Caoimh R, Sezgin D, O\u2019Donovan MR et al (2021) Prevalence of frailty in 62 countries across the world: a systematic review and meta-analysis of population-level studies. Age Ageing 50:96\u2013104. https:\/\/doi.org\/10.1093\/ageing\/afaa219","journal-title":"Age Ageing"},{"key":"3204_CR93","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-025-02088-5","author":"C Okoye","year":"2026","unstructured":"Okoye C, Stella V, Roumy L-G et al (2026) Frailty and postoperative risk in geriatric neurosurgery: a prospective cohort study using multidimensional assessment. GeroScience. https:\/\/doi.org\/10.1007\/s11357-025-02088-5","journal-title":"GeroScience"},{"key":"3204_CR94","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ejim.2018.02.021","volume":"56","author":"G Onder","year":"2018","unstructured":"Onder G, Vetrano DL, Marengoni A et al (2018) Accounting for frailty when treating chronic diseases. Eur J Intern Med 56:49\u201352. https:\/\/doi.org\/10.1016\/j.ejim.2018.02.021","journal-title":"Eur J Intern Med"},{"key":"3204_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2023.107616","volume":"226","author":"OP Owodunni","year":"2023","unstructured":"Owodunni OP, Roster K, Varela S et al (2023) Preoperative frailty risk in deep brain stimulation patients: Risk analysis index predicts Clavien-Dindo IV complications. Clin Neurol Neurosurg 226:107616. https:\/\/doi.org\/10.1016\/j.clineuro.2023.107616","journal-title":"Clin Neurol Neurosurg"},{"key":"3204_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.wnsx.2024.100286","volume":"23","author":"CC Paiz","year":"2024","unstructured":"Paiz CC, Owodunni OP, Courville EN et al (2024) Frailty Predicts 30-day mortality following major complications in neurosurgery patients: The risk analysis index has superior discrimination compared to modified frailty index-5 and increasing patient age. World Neurosurg X 23:100286. https:\/\/doi.org\/10.1016\/j.wnsx.2024.100286","journal-title":"World Neurosurg X"},{"issue":"1","key":"3204_CR97","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.cger.2019.09.002","volume":"36","author":"JA Palma","year":"2020","unstructured":"Palma JA, Kaufmann H (2020) Orthostatic Hypotension in Parkinson Disease. Clin Geriatr Med 36(1):53\u201367. https:\/\/doi.org\/10.1016\/j.cger.2019.09.002","journal-title":"Clin Geriatr Med"},{"key":"3204_CR98","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10143-020-01241-2","volume":"44","author":"J Pazniokas","year":"2021","unstructured":"Pazniokas J, Gandhi C, Theriault B et al (2021) The Immense Heterogeneity of Frailty in Neurosurgery: A Systematic Literature Review. Neurosurg Rev 44:189\u2013201. https:\/\/doi.org\/10.1007\/s10143-020-01241-2","journal-title":"Neurosurg Rev"},{"key":"3204_CR99","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1159\/000492572","volume":"65","author":"M Peball","year":"2019","unstructured":"Peball M, Mahlknecht P, Werkmann M et al (2019) Prevalence and Associated Factors of Sarcopenia and Frailty in Parkinson\u2019s Disease: A Cross-Sectional Study. Gerontology 65:216\u2013228. https:\/\/doi.org\/10.1159\/000492572","journal-title":"Gerontology"},{"key":"3204_CR100","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1179\/174313208X338052","volume":"31","author":"C Pellicano","year":"2009","unstructured":"Pellicano C, Benincasa D, Giovannelli M et al (2009) Entacapone in elderly Parkinsonian patients experiencing levodopa-related wearing-off: a pilot study. Neurol Res 31:74\u201376. https:\/\/doi.org\/10.1179\/174313208X338052","journal-title":"Neurol Res"},{"key":"3204_CR101","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000048874","volume":"105","author":"Y Peng","year":"2026","unstructured":"Peng Y, Ding A, Zhang S et al (2026) Post-marketing safety concerns with foscarbidopa\/foslevodopa: a pharmacovigilance study with disproportionality analysis based on FAERS. Medicine 105:e48874. https:\/\/doi.org\/10.1097\/MD.0000000000048874","journal-title":"Medicine"},{"issue":"4","key":"3204_CR102","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.3171\/2024.6.JNS24600","volume":"142","author":"NJ Pertsch","year":"2025","unstructured":"Pertsch NJ, Sakakura K, Kim D et al (2025) Frailty and outcomes after unilateral MRI-guided focused ultrasound thalamotomy for tremor. Journal of Neurosurgery 142(4):1196\u20131202. https:\/\/doi.org\/10.3171\/2024.6.JNS24600","journal-title":"Journal of Neurosurgery"},{"issue":"4","key":"3204_CR103","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1007\/s13311-020-00897-4","volume":"17","author":"RF Pfeiffer","year":"2020","unstructured":"Pfeiffer RF (2020) Autonomic dysfunction in Parkinson\u2019s disease. Neurotherapeutics 17(4):1464\u20131479. https:\/\/doi.org\/10.1007\/s13311-020-00897-4","journal-title":"Neurotherapeutics"},{"key":"3204_CR104","doi-asserted-by":"publisher","DOI":"10.1002\/ana.78143","author":"C Piat","year":"2025","unstructured":"Piat C, Mullan AF, Ghoniem K et al (2025) Autonomic Dysfunction and Risk of Mortality in Early-Onset Parkinson\u2019s Disease. Ann Neurol. https:\/\/doi.org\/10.1002\/ana.78143","journal-title":"Ann Neurol"},{"key":"3204_CR105","doi-asserted-by":"publisher","DOI":"10.3390\/nu14061220","volume":"14","author":"A Pignolo","year":"2022","unstructured":"Pignolo A, Mastrilli S, Dav\u00ec C et al (2022) Vitamin D and Parkinson\u2019s disease. Nutrients 14:1220. https:\/\/doi.org\/10.3390\/nu14061220","journal-title":"Nutrients"},{"key":"3204_CR106","doi-asserted-by":"publisher","first-page":"1279722","DOI":"10.3389\/fnagi.2023.1279722","volume":"15","author":"A Pilotto","year":"2023","unstructured":"Pilotto A, Rizzardi A, Zatti C et al (2023) Unsupervised but not supervised gait parameters are related to fatigue in Parkinson\u2019s disease: a pilot study. Front Aging Neurosci 15:1279722. https:\/\/doi.org\/10.3389\/fnagi.2023.1279722","journal-title":"Front Aging Neurosci"},{"key":"3204_CR107","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s40120-024-00635-4","volume":"13","author":"K Poplawska-Domaszewicz","year":"2024","unstructured":"Poplawska-Domaszewicz K, Batzu L, Falup-Pecurariu C, Chaudhuri KR (2024) Subcutaneous levodopa: a new engine for the vintage molecule. Neurol Ther 13:1055\u20131068. https:\/\/doi.org\/10.1007\/s40120-024-00635-4","journal-title":"Neurol Ther"},{"issue":"5","key":"3204_CR108","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1111\/ner.13347","volume":"24","author":"S Rahimpour","year":"2021","unstructured":"Rahimpour S, Gaztanaga W, Yadav AP, Chang SJ, Krucoff MO, Cajigas I, Turner DA, Wang DD (2021) Freezing of gait in Parkinson\u2019s disease: invasive and noninvasive neuromodulation. Neuromodulation 24(5):829\u2013842. https:\/\/doi.org\/10.1111\/ner.13347","journal-title":"Neuromodulation"},{"key":"3204_CR109","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1136\/jnnp-2024-334521","volume":"96","author":"R Rajalingam","year":"2025","unstructured":"Rajalingam R, Sorrento G, Fasano A (2025) Risk of fall with device-based advanced treatments in Parkinson\u2019s disease: a systematic review and network meta-analysis. J Neurol Neurosurg Psychiatry 96:470\u2013479. https:\/\/doi.org\/10.1136\/jnnp-2024-334521","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3204_CR110","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1080\/17425247.2025.2577710","volume":"23","author":"L Rigon","year":"2026","unstructured":"Rigon L, Fogliano C, Odin P, Antonini A (2026) Infusion therapies for Parkinson\u2019s disease: where are we in 2025? Expert Opin Drug Deliv 23:187\u2013190. https:\/\/doi.org\/10.1080\/17425247.2025.2577710","journal-title":"Expert Opin Drug Deliv"},{"key":"3204_CR111","doi-asserted-by":"publisher","first-page":"123","DOI":"10.14283\/jfa.2012.20","volume":"1","author":"KP Roland","year":"2012","unstructured":"Roland KP, Cornett KMD, Theou O et al (2012) Concurrence of Frailty and Parkinson\u2019s Disease. J Frailty Aging 1:123\u2013127. https:\/\/doi.org\/10.14283\/jfa.2012.20","journal-title":"J Frailty Aging"},{"issue":"5","key":"3204_CR112","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1093\/ageing\/afl041","volume":"35","author":"DB Rolfson","year":"2006","unstructured":"Rolfson DB, Majumdar SR, Tsuyuki RT, Tahir A, Rockwood K (2006) Validity and reliability of the Edmonton Frail Scale. Age Ageing 35(5):526\u2013529. https:\/\/doi.org\/10.1093\/ageing\/afl041Epub 2006 Jun 6. PMID: 16757522; PMCID: PMC5955195","journal-title":"Age Ageing"},{"key":"3204_CR113","doi-asserted-by":"publisher","first-page":"665","DOI":"10.23736\/S0390-5616.23.06007-1","volume":"67","author":"K Roster","year":"2023","unstructured":"Roster K, Moya A, Owodunni OP et al (2023) A cautionary tale: frailty predicts mortality after deep brain stimulation and the risk analysis index has an unparalleled classification threshold. J Neurosurg Sci 67:665\u2013667. https:\/\/doi.org\/10.23736\/S0390-5616.23.06007-1","journal-title":"J Neurosurg Sci"},{"key":"3204_CR114","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.parkreldis.2021.12.011","volume":"95","author":"JC Rothlind","year":"2022","unstructured":"Rothlind JC, York MK, Luo P et al (2022) Predictors of multi-domain cognitive decline following DBS for treatment of Parkinson\u2019s disease. Parkinsonism Relat Disord 95:23\u201327. https:\/\/doi.org\/10.1016\/j.parkreldis.2021.12.011","journal-title":"Parkinsonism Relat Disord"},{"key":"3204_CR115","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2026.01.017","author":"JG Ruiz","year":"2026","unstructured":"Ruiz JG, Oliva AA, Ramdas KN et al (2026) Randomized phase 2b dose-escalation trial of stem cell therapy with laromestrocel for aging frailty. Cell Stem Cell. https:\/\/doi.org\/10.1016\/j.stem.2026.01.017","journal-title":"Cell Stem Cell"},{"key":"3204_CR116","doi-asserted-by":"publisher","first-page":"102044","DOI":"10.1016\/j.arr.2023.102044","volume":"91","author":"S Salvioli","year":"2023","unstructured":"Salvioli S, Basile MS, Bencivenga L et al (2023) Biomarkers of aging in frailty and age-associated disorders: State of the art and future perspective. Ageing Res Rev 91:102044. https:\/\/doi.org\/10.1016\/j.arr.2023.102044","journal-title":"Ageing Res Rev"},{"key":"3204_CR117","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1089\/jpm.2019.0129","volume":"23","author":"LR Sankary","year":"2020","unstructured":"Sankary LR, Ford PJ, Machado AG et al (2020) Deep Brain Stimulation at End of Life: Clinical and Ethical Considerations. J Palliat Med 23:582\u2013585. https:\/\/doi.org\/10.1089\/jpm.2019.0129","journal-title":"J Palliat Med"},{"key":"3204_CR118","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0134118","volume":"10","author":"H Sawada","year":"2015","unstructured":"Sawada H, Oeda T, Umemura A et al (2015) Baseline C-Reactive Protein Levels and Life Prognosis in Parkinson Disease. PLoS One 10:e0134118. https:\/\/doi.org\/10.1371\/journal.pone.0134118","journal-title":"PLoS One"},{"issue":"1","key":"3204_CR119","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12877-019-1082-6","volume":"19","author":"BH Shaw","year":"2019","unstructured":"Shaw BH, Borrel D, Sabbaghan K, Kum C, Yang Y, Robinovitch SN, Claydon VE (2019) Relationships between orthostatic hypotension, frailty, falling and mortality in elderly care home residents. BMC Geriatr 19(1):80. https:\/\/doi.org\/10.1186\/s12877-019-1082-6 PMID: 30866845; PMCID: PMC6415493","journal-title":"BMC Geriatr"},{"key":"3204_CR120","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/ana.26410","volume":"92","author":"J Shen","year":"2022","unstructured":"Shen J, Amari N, Zack R et al (2022) Plasma MIA, CRP, and albumin predict cognitive decline in Parkinson\u2019s Disease. Ann Neurol 92:255\u2013269. https:\/\/doi.org\/10.1002\/ana.26410","journal-title":"Ann Neurol"},{"key":"3204_CR121","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1080\/14737175.2018.1535902","volume":"18","author":"J Siddiqui","year":"2018","unstructured":"Siddiqui J, Aldaajani Z, Mehanna R et al (2018) Rationale and patient selection for interventional therapies in Parkinson\u2019s disease. Expert Rev Neurother 18:811\u2013823. https:\/\/doi.org\/10.1080\/14737175.2018.1535902","journal-title":"Expert Rev Neurother"},{"key":"3204_CR122","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2026.108214","volume":"144","author":"S Singovski","year":"2026","unstructured":"Singovski S, Harl\u00e9 L, Zerbit J et al (2026) Continuous subcutaneous apomorphine infusion to improve comfort in advanced degenerative Parkinsonian syndrome patients: a retrospective descriptive study in a home-based setting. Parkinsonism Relat Disord 144:108214. https:\/\/doi.org\/10.1016\/j.parkreldis.2026.108214","journal-title":"Parkinsonism Relat Disord"},{"issue":"10","key":"3204_CR123","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1111\/jgs.18453","volume":"71","author":"SDM Sison","year":"2023","unstructured":"Sison SDM, Shi SM, Kim KM, Steinberg N, Jeong S, McCarthy EP, Kim DH (2023) A crosswalk of commonly used frailty scales. J Am Geriatr Soc 71(10):3189\u20133198. https:\/\/doi.org\/10.1111\/jgs.18453","journal-title":"J Am Geriatr Soc"},{"key":"3204_CR124","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2026.1798514","author":"C Skaaning","year":"2026","unstructured":"Skaaning C (2026) Levodopa-accelerated frailty: a hypothesis for a cumulative iatrogenic burden in Parkinson\u2019s disease. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2026.1798514","journal-title":"Front Neurol"},{"key":"3204_CR125","doi-asserted-by":"publisher","DOI":"10.1007\/s40520-024-02922-4","volume":"37","author":"MC Sousa-Fraguas","year":"2025","unstructured":"Sousa-Fraguas MC, Rodr\u00edguez-Fuentes G, Lastra-Barreira D, Conejo NM (2025) Associations between frailty and cognitive impairment in Parkinson\u00b4s disease: a cross-sectional study. Aging Clin Exp Res 37:19. https:\/\/doi.org\/10.1007\/s40520-024-02922-4","journal-title":"Aging Clin Exp Res"},{"key":"3204_CR126","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/S1474-4422(24)00355-7","volume":"23","author":"AJ Stoessl","year":"2024","unstructured":"Stoessl AJ (2024) Looking beyond the neurological diagnosis: considering frailty. Lancet Neurol 23:1072\u20131073. https:\/\/doi.org\/10.1016\/S1474-4422(24)00355-7","journal-title":"Lancet Neurol"},{"issue":"2","key":"3204_CR127","doi-asserted-by":"publisher","first-page":"e200591","DOI":"10.1212\/CPJ.0000000000200591","volume":"16","author":"I Subramanian","year":"2026","unstructured":"Subramanian I, Vaughan CL, Peteet JR, Hall K, LaFrance WC (2026) Spiritual Assess Neurologic Patients: Practical Approach Neurol Clin Pract 16(2):e200591. https:\/\/doi.org\/10.1212\/CPJ.0000000000200591","journal-title":"Spiritual Assess Neurologic Patients: Practical Approach Neurol Clin Pract"},{"key":"3204_CR128","doi-asserted-by":"publisher","first-page":"e30324","DOI":"10.1097\/MD.0000000000030324","volume":"101","author":"S Sun","year":"2022","unstructured":"Sun S, Wen Y, Li Y (2022) Serum albumin, cognitive function, motor impairment, and survival prognosis in Parkinson disease. Medicine 101:e30324. https:\/\/doi.org\/10.1097\/MD.0000000000030324","journal-title":"Medicine"},{"key":"3204_CR129","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.3945\/ajcn.112.051664","volume":"97","author":"M Suzuki","year":"2013","unstructured":"Suzuki M, Yoshioka M, Hashimoto M et al (2013) Randomized, double-blind, placebo-controlled trial of vitamin D supplementation in Parkinson disease. Am J Clin Nutr 97:1004\u20131013. https:\/\/doi.org\/10.3945\/ajcn.112.051664","journal-title":"Am J Clin Nutr"},{"key":"3204_CR130","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/ageing\/27.3.411-a","volume":"27","author":"C Swinne","year":"1998","unstructured":"Swinne C, Cornette P, Schoevaerdts D et al (1998) Frailty in the medical literature. Age Ageing 27:411\u2013413. https:\/\/doi.org\/10.1093\/ageing\/27.3.411-a","journal-title":"Age Ageing"},{"key":"3204_CR131","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41531-023-00447-7","volume":"9","author":"Y Tang","year":"2023","unstructured":"Tang Y, Han L, Li S et al (2023) Plasma GFAP in Parkinson\u2019s disease with cognitive impairment and its potential to predict conversion to dementia. NPJ Parkinsons Dis 9:23. https:\/\/doi.org\/10.1038\/s41531-023-00447-7","journal-title":"NPJ Parkinsons Dis"},{"key":"3204_CR132","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s10143-025-03567-1","volume":"48","author":"L Tariciotti","year":"2025","unstructured":"Tariciotti L, Bertani G, Lanfranchi M et al (2025) The impact of frailty on functional recovery and discharge dispositions in patients undergoing urgent neurosurgical care. Neurosurg Rev 48:422. https:\/\/doi.org\/10.1007\/s10143-025-03567-1","journal-title":"Neurosurg Rev"},{"key":"3204_CR133","doi-asserted-by":"publisher","first-page":"453","DOI":"10.14802\/jmd.24114","volume":"17","author":"T Tezuka","year":"2024","unstructured":"Tezuka T, Nukariya T, Kizuka Y et al (2024) Potential Psychosis Induced by a Sustained High Plasma Levodopa Concentration Due to Continuous Subcutaneous Foslevodopa\/Foscarbidopa Infusion in a Patient With Parkinson\u2019s Disease: A Case Report. J Mov Disord 17:453\u2013455. https:\/\/doi.org\/10.14802\/jmd.24114","journal-title":"J Mov Disord"},{"key":"3204_CR134","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s00702-022-02498-1","volume":"129","author":"L T\u00f6nges","year":"2022","unstructured":"T\u00f6nges L, Buhmann C, Klebe S et al (2022) Blood-based biomarker in Parkinson\u2019s disease: potential for future applications in clinical research and practice. J Neural Transm 129:1201. https:\/\/doi.org\/10.1007\/s00702-022-02498-1","journal-title":"J Neural Transm"},{"key":"3204_CR135","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000547128","volume":"104","author":"C Venero","year":"2026","unstructured":"Venero C, Roy JM, Ghurye N et al (2026) Frailty indices in patients undergoing functional neurosurgical procedures: a systematic review. Stereotact Funct Neurosurg 104:55\u201364. https:\/\/doi.org\/10.1159\/000547128","journal-title":"Stereotact Funct Neurosurg"},{"key":"3204_CR136","doi-asserted-by":"publisher","first-page":"e463","DOI":"10.1093\/geront\/gnaa061","volume":"61","author":"M Welstead","year":"2021","unstructured":"Welstead M, Jenkins ND, Russ TC et al (2021) A systematic review of frailty trajectories: their shape and influencing factors. Gerontologist 61:e463\u2013e475. https:\/\/doi.org\/10.1093\/geront\/gnaa061","journal-title":"Gerontologist"},{"key":"3204_CR137","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1002\/mds.26563","volume":"31","author":"CH Williams-Gray","year":"2016","unstructured":"Williams-Gray CH, Wijeyekoon R, Yarnall AJ et al (2016) Serum immune markers and disease progression in an incident Parkinson\u2019s disease cohort (ICICLE-PD). Mov Disord 31:995\u20131003. https:\/\/doi.org\/10.1002\/mds.26563","journal-title":"Mov Disord"},{"key":"3204_CR138","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.533731","volume":"11","author":"T Yang","year":"2020","unstructured":"Yang T, Zhan Z, Zhang L, Zhu J, Liu Y, Ge J, Zhao Y, Dong J (2020) Prevalence and risk factors for malnutrition in patients with Parkinson\u2019s disease. Front Neurol 11:533731. https:\/\/doi.org\/10.3389\/fneur.2020.533731","journal-title":"Front Neurol"},{"issue":"9","key":"3204_CR139","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.3390\/nu14091812","volume":"14","author":"RY Yang","year":"2022","unstructured":"Yang RY, Yang AY, Chen YC, Lee SD, Lee SH, Chen JW (2022) Association between dysphagia and frailty in older adults: a systematic review and meta-analysis. Nutrients 14(9):1812. https:\/\/doi.org\/10.3390\/nu14091812","journal-title":"Nutrients"},{"key":"3204_CR140","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3233\/JPD-212866","volume":"12","author":"E Ygland R\u00f6dstr\u00f6m","year":"2022","unstructured":"Ygland R\u00f6dstr\u00f6m E, Mattsson-Carlgren N, Janelidze S et al (2022) Serum neurofilament light chain as a marker of progression in Parkinson\u2019s disease: long-term observation and implications of clinical subtypes. Journal of Parkinson\u2019s Disease 12:571\u2013584. https:\/\/doi.org\/10.3233\/JPD-212866","journal-title":"Journal of Parkinson's Disease"},{"key":"3204_CR141","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1002\/mds.30069","volume":"40","author":"N Yoshihara","year":"2025","unstructured":"Yoshihara N, Nishikawa N, Watanabe R, Hattori N (2025) Skin inflammatory reactions in patients with continuous subcutaneous injection of foslevodopa-foscarbidopa hydrate: histopathology. Movement Disorders 40:378\u2013379. https:\/\/doi.org\/10.1002\/mds.30069","journal-title":"Movement Disorders"},{"key":"3204_CR142","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2024-088030","volume":"15","author":"X Yu","year":"2025","unstructured":"Yu X, Wang D, Yao L et al (2025) Sleep disorders and the association with frailty among community-dwelling older adults in Northwest China: a cross-sectional study. BMJ Open 15:e088030. https:\/\/doi.org\/10.1136\/bmjopen-2024-088030","journal-title":"BMJ Open"},{"key":"3204_CR143","doi-asserted-by":"publisher","first-page":"112333","DOI":"10.1016\/j.exger.2023.112333","volume":"184","author":"RS Zeidan","year":"2023","unstructured":"Zeidan RS, McElroy T, Rathor L et al (2023) Sex differences in frailty among older adults. Exp Gerontol 184:112333. https:\/\/doi.org\/10.1016\/j.exger.2023.112333","journal-title":"Exp Gerontol"},{"issue":"4","key":"3204_CR144","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/ane.13141","volume":"140","author":"HJ Zhang","year":"2019","unstructured":"Zhang HJ, Zhang JR, Mao CJ et al (2019) Relationship between 25-Hydroxyvitamin D, bone density, and Parkinson\u2019s disease symptoms. Acta Neurol Scand 140(4):274\u2013280. https:\/\/doi.org\/10.1111\/ane.13141Epub 2019 Aug 6. PMID: 31389003.;","journal-title":"Acta Neurol Scand"},{"key":"3204_CR145","doi-asserted-by":"publisher","first-page":"816315","DOI":"10.3389\/fneur.2022.816315","volume":"13","author":"L-L Zhang","year":"2022","unstructured":"Zhang L-L, Zhang L, Dong J et al (2022) Factors Contributing to Malnutrition in Parkinson\u2019s Disease Patients With Freezing of Gait. Front Neurol 13:816315. https:\/\/doi.org\/10.3389\/fneur.2022.816315","journal-title":"Front Neurol"},{"key":"3204_CR146","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1001\/jamaneurol.2023.0183","volume":"80","author":"Z Zheng","year":"2023","unstructured":"Zheng Z, Lv Y, Rong S et al (2023) Physical Frailty, Genetic Predisposition, and Incident Parkinson Disease. JAMA Neurol 80:455\u2013461. https:\/\/doi.org\/10.1001\/jamaneurol.2023.0183","journal-title":"JAMA Neurol"},{"key":"3204_CR147","doi-asserted-by":"publisher","first-page":"108766","DOI":"10.1016\/j.sleep.2026.108766","volume":"139","author":"S Zhu","year":"2026","unstructured":"Zhu S, An D, Liu X (2026) Obstructive sleep apnea, biomarker profiles, and clinical progression in Parkinson\u2019s disease: Longitudinal effects of CPAP therapy. Sleep Med 139:108766. https:\/\/doi.org\/10.1016\/j.sleep.2026.108766","journal-title":"Sleep Med"},{"key":"3204_CR148","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ejim.2018.06.012","volume":"56","author":"A Zucchelli","year":"2018","unstructured":"Zucchelli A, Vetrano DL, Marengoni A et al (2018) Frailty predicts short-term survival even in older adults without multimorbidity. Eur J Intern Med 56:53\u201356. https:\/\/doi.org\/10.1016\/j.ejim.2018.06.012","journal-title":"Eur J Intern Med"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-026-03204-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-026-03204-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-026-03204-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T14:49:18Z","timestamp":1787410158000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-026-03204-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,22]]},"references-count":148,"alternative-id":["3204"],"URL":"https:\/\/doi.org\/10.1007\/s00702-026-03204-1","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,22]]},"assertion":[{"value":"3 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}